BG
LXRX icon

BlackRock Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

BlackRock Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$769K Buy
55,655
+4,927
+10% +$79.1K ﹤0.01% 2229
2016
Q3 		$917K Buy
50,728
+35,749
+239% +$575K ﹤0.01% 2078
2016
Q2 		$215K Buy
14,979
+762
+5% +$10.3K ﹤0.01% 2557
2016
Q1 		$170K Buy
14,217
+5,158
+57% +$54.1K ﹤0.01% 2623
2015
Q4 		$121K Sell
9,059
-329
-4% -$4.04K ﹤0.01% 2633
2015
Q3 		$101K Buy
+9,388
New +$103K ﹤0.01% 2705
2015
Q1 		– Sell
-1,401
Closed -$9K – 2870
2014
Q4 		$9K Hold
1,401
– – ﹤0.01% 2855
2014
Q3 		$14K Buy
+1,401
New +$15K ﹤0.01% 2781

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return